USD 0.69
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 765 Thousand USD | -44.81% |
2022 | 1.38 Million USD | 30.26% |
2021 | 1.06 Million USD | -11.11% |
2020 | 1.19 Million USD | -2.68% |
2019 | 1.23 Million USD | -4.58% |
2018 | 1.28 Million USD | 2.38% |
2017 | 1.25 Million USD | -3.75% |
2016 | 1.3 Million USD | 6.17% |
2015 | 1.23 Million USD | 4.5% |
2014 | 1.17 Million USD | 18.61% |
2013 | 994 Thousand USD | -3.87% |
2012 | 1.03 Million USD | 9.19% |
2011 | 947 Thousand USD | -7.07% |
2010 | 1.01 Million USD | 11.0% |
2009 | 918 Thousand USD | -4.47% |
2008 | 961 Thousand USD | -8.65% |
2007 | 1.05 Million USD | 11.56% |
2006 | 943 Thousand USD | -34.83% |
2005 | 1.44 Million USD | 4.55% |
2004 | 1.38 Million USD | -1.91% |
2003 | 1.41 Million USD | 1.8% |
2002 | 1.38 Million USD | -1.14% |
2001 | 1.4 Million USD | -44.8% |
2000 | 2.54 Million USD | -0.78% |
1999 | 2.56 Million USD | -22.49% |
1998 | 3.3 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 471 Thousand USD | 93.83% |
2024 Q2 | 431 Thousand USD | -7.22% |
2023 Q2 | 242 Thousand USD | 86.15% |
2023 FY | 745 Thousand USD | -46.25% |
2023 Q1 | 130 Thousand USD | -74.41% |
2023 Q3 | 151 Thousand USD | -37.6% |
2023 Q4 | 243 Thousand USD | 60.93% |
2022 FY | 1.38 Million USD | 30.26% |
2022 Q3 | 221 Thousand USD | -24.32% |
2022 Q2 | 292 Thousand USD | -18.89% |
2022 Q1 | 360 Thousand USD | 44.58% |
2022 Q4 | 508 Thousand USD | 129.86% |
2021 Q2 | 249 Thousand USD | -16.44% |
2021 Q1 | 298 Thousand USD | 16.41% |
2021 FY | 1.06 Million USD | -11.11% |
2021 Q3 | 268 Thousand USD | 7.63% |
2021 Q4 | 249 Thousand USD | -7.09% |
2020 Q4 | 256 Thousand USD | -13.8% |
2020 FY | 1.19 Million USD | -2.68% |
2020 Q3 | 297 Thousand USD | -13.16% |
2020 Q1 | 302 Thousand USD | 11.85% |
2020 Q2 | 342 Thousand USD | 13.25% |
2019 Q1 | 308 Thousand USD | -13.24% |
2019 Q4 | 270 Thousand USD | -5.92% |
2019 Q2 | 365 Thousand USD | 18.51% |
2019 Q3 | 287 Thousand USD | -21.37% |
2019 FY | 1.23 Million USD | -4.58% |
2018 Q3 | 268 Thousand USD | -30.93% |
2018 FY | 1.28 Million USD | 2.38% |
2018 Q4 | 355 Thousand USD | 32.46% |
2018 Q1 | 278 Thousand USD | -16.27% |
2018 Q2 | 388 Thousand USD | 39.57% |
2017 Q4 | 332 Thousand USD | 19.42% |
2017 Q1 | 295 Thousand USD | -15.47% |
2017 Q3 | 278 Thousand USD | -21.47% |
2017 Q2 | 354 Thousand USD | 20.0% |
2017 FY | 1.25 Million USD | -3.75% |
2016 Q1 | 310 Thousand USD | 13.14% |
2016 Q4 | 349 Thousand USD | 17.11% |
2016 FY | 1.3 Million USD | 6.17% |
2016 Q3 | 298 Thousand USD | -15.1% |
2016 Q2 | 351 Thousand USD | 13.23% |
2015 Q1 | 349 Thousand USD | 15.18% |
2015 Q4 | 274 Thousand USD | -5.84% |
2015 Q3 | 291 Thousand USD | -8.49% |
2015 FY | 1.23 Million USD | 4.5% |
2015 Q2 | 318 Thousand USD | -8.88% |
2014 Q2 | 309 Thousand USD | 19.31% |
2014 Q3 | 308 Thousand USD | -0.32% |
2014 Q4 | 303 Thousand USD | -1.62% |
2014 FY | 1.17 Million USD | 18.61% |
2014 Q1 | 259 Thousand USD | -2.63% |
2013 Q3 | 181 Thousand USD | -43.79% |
2013 FY | 994 Thousand USD | -3.87% |
2013 Q2 | 322 Thousand USD | 41.85% |
2013 Q1 | 227 Thousand USD | -14.98% |
2013 Q4 | 266 Thousand USD | 46.96% |
2012 Q3 | 279 Thousand USD | 32.86% |
2012 Q4 | 267 Thousand USD | -4.3% |
2012 Q1 | 278 Thousand USD | 36.27% |
2012 FY | 1.03 Million USD | 9.19% |
2012 Q2 | 210 Thousand USD | -24.46% |
2011 Q4 | 204 Thousand USD | -20.0% |
2011 Q2 | 226 Thousand USD | -13.74% |
2011 Q1 | 262 Thousand USD | 9.17% |
2011 Q3 | 255 Thousand USD | 12.83% |
2011 FY | 947 Thousand USD | -7.07% |
2010 Q2 | 253 Thousand USD | 2.85% |
2010 Q3 | 280 Thousand USD | 10.67% |
2010 Q4 | 240 Thousand USD | -14.29% |
2010 FY | 1.01 Million USD | 11.0% |
2010 Q1 | 246 Thousand USD | 20.0% |
2009 Q3 | 239 Thousand USD | -1.65% |
2009 Q2 | 243 Thousand USD | 4.29% |
2009 Q1 | 233 Thousand USD | 7.87% |
2009 FY | 918 Thousand USD | -4.47% |
2009 Q4 | 205 Thousand USD | -14.23% |
2008 Q1 | 287 Thousand USD | 21.1% |
2008 Q4 | 216 Thousand USD | -9.62% |
2008 FY | 961 Thousand USD | -8.65% |
2008 Q2 | 219 Thousand USD | -23.69% |
2008 Q3 | 239 Thousand USD | 9.13% |
2007 Q1 | 317 Thousand USD | 934.21% |
2007 Q4 | 237 Thousand USD | 30.22% |
2007 Q3 | 182 Thousand USD | -42.41% |
2007 Q2 | 316 Thousand USD | -0.32% |
2007 FY | 1.05 Million USD | 11.56% |
2006 Q1 | 358 Thousand USD | 5.92% |
2006 Q3 | -348 Thousand USD | -207.74% |
2006 Q4 | -38 Thousand USD | 89.08% |
2006 FY | 943 Thousand USD | -34.83% |
2006 Q2 | 323 Thousand USD | -9.78% |
2005 FY | 1.44 Million USD | 4.55% |
2005 Q3 | 307 Thousand USD | -25.85% |
2005 Q4 | 338 Thousand USD | 10.1% |
2005 Q2 | 414 Thousand USD | 6.7% |
2005 Q1 | 388 Thousand USD | 29.77% |
2004 FY | 1.38 Million USD | -1.91% |
2004 Q3 | 401 Thousand USD | 9.26% |
2004 Q1 | 317 Thousand USD | 3.93% |
2004 Q2 | 367 Thousand USD | 15.77% |
2004 Q4 | 299 Thousand USD | -25.44% |
2003 Q3 | 386 Thousand USD | 7.82% |
2003 FY | 1.41 Million USD | 1.8% |
2003 Q1 | 361 Thousand USD | -0.28% |
2003 Q4 | 305 Thousand USD | -20.98% |
2003 Q2 | 358 Thousand USD | -0.83% |
2002 Q3 | 361 Thousand USD | 10.4% |
2002 Q4 | 362 Thousand USD | 0.28% |
2002 FY | 1.38 Million USD | -1.14% |
2002 Q1 | 336 Thousand USD | -33.07% |
2002 Q2 | 327 Thousand USD | -2.68% |
2001 Q3 | 294 Thousand USD | 7.3% |
2001 Q2 | 274 Thousand USD | -17.47% |
2001 Q1 | 332 Thousand USD | -53.44% |
2001 FY | 1.4 Million USD | -44.8% |
2001 Q4 | 502 Thousand USD | 70.75% |
2000 Q4 | 713 Thousand USD | 0.71% |
2000 FY | 2.54 Million USD | -0.78% |
2000 Q3 | 708 Thousand USD | 24.65% |
2000 Q2 | 568 Thousand USD | 0.0% |
1999 Q4 | 653 Thousand USD | 2.51% |
1999 Q2 | 604 Thousand USD | 0.0% |
1999 FY | 2.56 Million USD | -22.49% |
1999 Q3 | 637 Thousand USD | 5.46% |
1998 FY | 3.3 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
The Amacore Group, Inc. | 64.06 Million USD | 98.806% |
Arem Pacific Corporation | 367.08 Thousand USD | -108.401% |
Assisted 4 Living, Inc. | 833.9 Thousand USD | 8.263% |
BioCorRx Inc. | 3.84 Million USD | 80.083% |
Bionik Laboratories Corp. | 5.81 Million USD | 86.844% |
Banyan Corp. | 6.59 Million USD | 88.405% |
Clearday, Inc. | 5 Million USD | 84.708% |
Dental Patient Care America, Inc. | 3.27 Million USD | 76.647% |
Quantum Medical Transport, Inc. | 874.76 USD | -87352.558% |
Empower Clinics Inc. | 6.92 Million USD | 88.949% |
First Choice Healthcare Solutions, Inc. | 2.44 Million USD | 68.653% |
Selectis Health, Inc. | 14.36 Million USD | 94.675% |
Ethema Health Corporation | 5.27 Million USD | 85.49% |
HealthLynked Corp. | 9.73 Million USD | 92.139% |
HQDA Elderly Life Network Corp. | - USD | -Infinity% |
Healthcare Solutions Management Group, Inc. | 9.43 Million USD | 91.895% |
JRSIS Health Care Corporation | 671.64 Thousand USD | -13.899% |
Comjoyful International Company | - USD | -Infinity% |
Medical Facilities Corporation | 75.35 Million USD | 98.985% |
MedSmart Group Inc. | 65.47 Thousand USD | -1068.456% |
North America Frac Sand, Inc. | 775.75 Thousand USD | 1.386% |
Nova Leap Health Corp. | 9.3 Million USD | 91.781% |
Nexteligent Holdings, Inc. | 553.38 Thousand USD | -38.239% |
PAO Group, Inc. | 45.42 Thousand USD | -1584.28% |
Primemd Inc. | 6.25 Million USD | 87.775% |
Raffles Medical Group Ltd | 151.69 Million USD | 99.496% |
Ryman Healthcare Limited | 9.61 Million USD | 92.042% |
Stem Cell Authority, Ltd. | 4233.00 USD | -17972.289% |
SETO Holdings, Inc. | - USD | -Infinity% |
Optima Medical Innovations Corp. | 1.38 Million USD | 44.596% |
Mycotopia Therapies, Inc. | 616.72 Thousand USD | -24.043% |
Veltex Corporation | 1.77 Million USD | 56.953% |
World Financial Holding Group | 28.42 Thousand USD | -2591.198% |
Xcelerate Inc. | 2.9 Million USD | 73.682% |